XML 34 R21.htm IDEA: XBRL DOCUMENT v3.25.3
Earnings per Share/Capital Stock (Tables)
 9 Months Ended
Sep. 30, 2025
Earnings Per Share [Abstract]  
Schedule of reconciliation of Registrant's net income and weighted average Common Shares outstanding for calculating basic net income per share
The following is a reconciliation of Registrant’s net income and weighted average Common Shares outstanding used to calculate basic EPS:
Basic: For The Three Months Ended 
 September 30,		 For The Nine Months Ended 
 September 30,
(in thousands, except per share amounts)2025202420252024
Net income$41,167 $35,834 $101,701 $90,833 
Less: impact from participating securities164 128 370 294 
Total income available to common shareholders$41,003 $35,706 $101,331 $90,539 
Weighted average Common Shares outstanding, basic38,567 37,564 38,444 37,302 
Basic earnings per Common Share$1.06 $0.95 $2.64 $2.43 
Schedule of reconciliation of Registrant's net income and weighted average Common Shares outstanding for calculating diluted net income per share
The following is a reconciliation of Registrant’s net income and weighted average Common Shares outstanding used to calculate diluted EPS:
Diluted: For The Three Months Ended 
 September 30,		 For The Nine Months Ended 
 September 30,
(in thousands, except per share amounts)2025202420252024
Common shareholders earnings, basic$41,003 $35,706 $101,331 $90,539 
Undistributed earnings for dilutive restricted stock units
86 66 169 134 
Total common shareholders earnings, diluted$41,089 $35,772 $101,500 $90,673 
Weighted average Common Shares outstanding, basic38,567 37,564 38,444 37,302 
Stock-based compensation (1)
135 119 125 107 
Weighted average Common Shares outstanding, diluted38,702 37,683 38,569 37,409 
Diluted earnings per Common Share$1.06 $0.95 $2.63 $2.42 
(1)     In applying the treasury stock method of reflecting the dilutive effect of outstanding stock-based compensation in calculating diluted EPS, 154,489 and 135,575 restricted stock units, including performance awards to officers of the Company at September 30, 2025 and 2024, respectively, were deemed to be outstanding and included in the calculation of diluted EPS.